Source: GSK Consumer Healthcare India
GlaxoSmithKline is putting Horlicks for sale to find a buyer of the remaining $13 billion stake in its consumer healthcare joint venture with Novartis. The deal with Novartis will give GSK full control of a plethora of healthcare products. The company said: “GSK is initiating a strategic review of Horlicks and its other consumer healthcare nutrition products to support funding of the transaction, and to drive increased focus on over-the-counter and oral health categories. Combined sales of these products were approximately £550m in 2017.”
Source: The Guardian
